TRANSLATE BIO, INC. Item 8.01 Other Events.
On
Cautionary Note Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995. Such
forward-looking statements include, but are not limited to, those regarding: the
Company's expectations regarding interruptions in patient enrollment, dosing and
follow-up in the ongoing Phase 1/2 clinical trial of MRT5005; the Company's
expectations on when it will report interim data from the additional SAD group
and the MAD portion of the trial; and the Company's plans, strategies and
prospects for its business, including its lead development programs. The words
"anticipate," "believe," "continue," "could," "estimate," "expect," "forward,"
"intend," "may," "plan," "potential," "predict," "project," "should," "target,"
"would" and similar expressions are intended to identify forward-looking
statements, although not all forward-looking statements contain these
identifying words. Such statements are subject to numerous important factors,
risks and uncertainties that may cause actual events or results to differ
materially from current expectations and beliefs, including but not limited to:
the Company's ability to advance the development of its platform and programs
under the timelines it projects, demonstrate the requisite safety and efficacy
of its product candidates and replicate in clinical trials any positive findings
from preclinical studies; the content and timing of decisions made by the FDA,
other regulatory authorities and investigational review boards at clinical trial
sites, including decisions as it relates to ongoing and planned clinical trials;
the Company's ability to obtain, maintain and enforce necessary patent and other
intellectual property protection; the availability of significant cash required
to fund operations; competitive factors; the COVID-19 pandemic; general economic
and market conditions and other important risk factors set forth under the
caption "Risk Factors" in the Company's Annual Report on Form 10-K for the
fiscal year ended
--------------------------------------------------------------------------------
© Edgar Online, source
